Table:
begin	end	state
1	36	cytoplasmic
37	56	transmembrane
57	79	non-cytoplasmic
80	102	transmembrane
103	108	cytoplasmic
109	133	transmembrane
134	161	non-cytoplasmic
162	180	transmembrane
181	237	cytoplasmic
238	257	transmembrane
258	262	non-cytoplasmic
263	288	transmembrane
289	602	cytoplasmic

Input:
>WP_013091122.1 NCBI__GCF_000092885.1:WP_013091122.1
MNDTAELANPQLAAAHADALRERADYRIVPAKNRARLAGTVAAVLLIGIVLESVLGNPRW
GWNVFAEWFLSEPVLSGLGRTLLLTALGAAFGFALGVPIALARVSRSPLLAGCAWAFVWL
FRSIPLIVLLLILNNLGYLYETVHLGLPFTSVVVLDVPTTELISPFLAAVLGLTLNHAAF
SAEVIRGGIQSVDHGQLEAAAALGLPRERQARRIVLPQAMRAIVPTAFNDLIALAKGSSM
VYVLAMPELFYTVQIIYRRNLEVIPLLMVATVWYLIILTVLSAIQVYVERHFSRGVKRSA
VPSAFGALLKSMGIARGGDVAHVEPFGDAKDNARAGASASLDQRWADQRDGARITIQQVS
KSFGTLKVLDNVSLTMRPGSVTVILGQSGSGKSTLLRTINHLERVDGGLIDIDGELIGYR
RDGDTLYELKEKEVLRRRVEVGMVFQSFNLFPHLTVLENIIEAPVALGRLSRAEAESLAL
SLLARVGLEAKAHAWPRQLSGGQQQRVAIARALALKPKVLLFDEPTSALDPELVNEVLDV
IKALARSGTTMVIVTHEIGFAREVADTIVFMDRGRVIESGPPAQVLNEPRHARTREFLSR
VL

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server